Literature DB >> 24943834

Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes.

A Poloni1, G Maurizi1, D Mattiucci1, S Amatori2, B Fogliardi2, B Costantini1, M Mariani1, S Mancini1, A Olivieri1, M Fanelli2, P Leoni1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24943834     DOI： 10.1038/leu.2014.197

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion.

Authors:  Antonella Poloni; Giulia Maurizi; Lucia Babini; Federica Serrani; Eleonora Berardinelli; Stefania Mancini; Benedetta Costantini; Giancarlo Discepoli; Pietro Leoni
Journal:  Cell Transplant       Date:  2010-11-05       Impact factor: 4.064

2.  Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway.

Authors:  Konstantia Pavlaki; Charalampos G Pontikoglou; Anthi Demetriadou; Aristea K Batsali; Athina Damianaki; Emmanouil Simantirakis; Michail Kontakis; Athanasios Galanopoulos; Ioannis Kotsianidis; Maria-Christina Kastrinaki; Helen A Papadaki
Journal:  Stem Cells Dev       Date:  2014-04-21       Impact factor: 3.272

3.  Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes.

Authors:  S Tauro; M D Hepburn; C M Peddie; D T Bowen; M J Pippard
Journal:  Leukemia       Date:  2002-05       Impact factor: 11.528

4.  Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells.

Authors:  S Geyh; S Oz; R-P Cadeddu; J Fröbel; B Brückner; A Kündgen; R Fenk; I Bruns; C Zilkens; D Hermsen; N Gattermann; G Kobbe; U Germing; F Lyko; R Haas; T Schroeder
Journal:  Leukemia       Date:  2013-03-29       Impact factor: 11.528

5.  How to track cellular aging of mesenchymal stromal cells?

Authors:  Wolfgang Wagner; Simone Bork; Günther Lepperdinger; Sylvia Joussen; Nan Ma; Dirk Strunk; Carmen Koch
Journal:  Aging (Albany NY)       Date:  2010-04       Impact factor: 5.682

Review 6.  Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome.

Authors:  Daniella B Kerbauy; H Joachim Deeg
Journal:  Exp Hematol       Date:  2007-11       Impact factor: 3.084

Review 7.  Myelodysplastic syndromes: molecular pathogenesis and genomic changes.

Authors:  Florian Nolte; Wolf-K Hofmann
Journal:  Ann Hematol       Date:  2008-05-31       Impact factor: 3.673

8.  [Methylation status of LINE-1 sequences in patients with MDS or secondary AML].

Authors:  D Römermann; B Hasemeier; K Metzig; B Schlegelberger; F Länger; H Kreipe; U Lehmann
Journal:  Verh Dtsch Ges Pathol       Date:  2007

9.  Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes.

Authors:  Antonella Poloni; Gaia Goteri; Antonio Zizzi; Federica Serrani; Silvia Trappolini; Benedetta Costantini; Marianna Mariani; Attilio Olivieri; Massimo Catarini; Riccardo Centurioni; Francesco Alesiani; Federica Giantomassi; Daniela Stramazzotti; Simona Biagetti; Simona Alfonsi; Eleonora Berardinelli; Pietro Leoni
Journal:  Eur J Haematol       Date:  2013-06-28       Impact factor: 3.674

10.  An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.

Authors:  Clara Guerzoni; Stefano Amatori; Luca Giorgi; Maria Cristina Manara; Lorena Landuzzi; Pier-Luigi Lollini; Aurora Tassoni; Mauro Balducci; Marco Manfrini; Loredana Pratelli; Massimo Serra; Piero Picci; Mauro Magnani; Vieri Fusi; Mirco Fanelli; Katia Scotlandi
Journal:  BMC Cancer       Date:  2014-02-27       Impact factor: 4.430
View more
  2 in total

Review 1.  The Bone Marrow Microenvironment in Health and Myeloid Malignancy.

Authors:  Marta Galán-Díez; Álvaro Cuesta-Domínguez; Stavroula Kousteni
Journal:  Cold Spring Harb Perspect Med       Date:  2018-07-02       Impact factor: 6.915

Review 2.  Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.

Authors:  Domenico Mattiucci; Giulia Maurizi; Pietro Leoni; Antonella Poloni
Journal:  Cell Transplant       Date:  2018-04-23       Impact factor: 4.064
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.